{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:45:20Z","timestamp":1791089120610,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T00:00:00Z","timestamp":1355788800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00436-012-3222-1","type":"journal-article","created":{"date-parts":[[2012,12,16]],"date-time":"2012-12-16T19:53:19Z","timestamp":1355687599000},"page":"1001-1009","source":"Crossref","is-referenced-by-count":19,"title":["Visceral and post-Kala-Azar dermal leishmaniasis isolates show significant difference in their in vitro drug susceptibility pattern"],"prefix":"10.1007","volume":"112","author":[{"given":"Jyotsna","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rentala","family":"Madhubala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarman","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,18]]},"reference":[{"key":"3222_CR1","first-page":"341","volume":"70","author":"M Addy","year":"1992","unstructured":"Addy M, Nandy A (1992) Ten years of Kala-Azar in west Bengal, part I. Did post-Kala-Azar dermal leishmaniasis initiate the outbreak in 24-Parganas? Bull World Health Organ 70:341\u2013346","journal-title":"Bull World Health Organ"},{"key":"3222_CR2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1099\/jmm.0.46841-0","volume":"56","author":"SS Ashutosh","year":"2007","unstructured":"Ashutosh SS, Goyal N (2007) Molecular mechanisms of antimony resistance in Leishmania. J Med Microbiol 56:143\u2013153","journal-title":"J Med Microbiol"},{"key":"3222_CR3","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.4269\/ajtmh.2006.75.1074","volume":"75","author":"M Calvopina","year":"2006","unstructured":"Calvopina M, Gomez EA, Sindermann H, Cooper PJ, Hashiguchi Y (2006) Relapse of new world diffuse cutaneous leishmaniasis caused by Leishmania (Leishmania) mexicana after miltefosine treatment. Am J Trop Med Hyg 75:1074\u20131077","journal-title":"Am J Trop Med Hyg"},{"key":"3222_CR4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1475-9292-6-5","volume":"6","author":"JP Oliveira de","year":"2007","unstructured":"de Oliveira JP, Fernandes F, Cruz AK, Trombela V, Monteiro E, Camargo AA, Barral A, de Oliveira CI (2007) Genetic diversity of Leishmania amazonensis strains isolated in northeastern Brazil as revealed by DNA sequencing, PCR-based analyses and molecular karyotyping. Kinetoplastid Biol Dis 6:5","journal-title":"Kinetoplastid Biol Dis"},{"key":"3222_CR5","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1128\/AAC.49.11.4616-4621.2005","volume":"49","author":"S Decuypere","year":"2005","unstructured":"Decuypere S, Rijal S, Yardley V, De DS, Laurent T, Khanal B, Chappuis F, Dujardin JC (2005) Gene expression analysis of the mechanism of natural Sb(V) resistance in Leishmania donovani isolates from Nepal. Antimicrob Agents Chemother 49:4616\u20134621","journal-title":"Antimicrob Agents Chemother"},{"key":"3222_CR6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.meegid.2006.09.001","volume":"7","author":"A Dey","year":"2007","unstructured":"Dey A, Singh S (2007) Genetic heterogeneity among visceral and post-Kala-Azar dermal leishmaniasis strains from eastern India. Infect Genet Evol 7:219\u2013222","journal-title":"Infect Genet Evol"},{"key":"3222_CR7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.parint.2005.01.001","volume":"54","author":"A Dutta","year":"2005","unstructured":"Dutta A, Bandyopadhyay S, Mandal C, Chatterjee M (2005) Development of a modified MTT assay for screening antimonial resistant field isolates of Indian visceral leishmaniasis. Parasitol Int 54:119\u2013122","journal-title":"Parasitol Int"},{"key":"3222_CR8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/expr.2001.4592","volume":"97","author":"NO El Tai","year":"2001","unstructured":"El Tai NO, El FM, Mauricio I, Miles MA, Oskam L, El Safi SH, Presber WH, Schonian G (2001) Leishmania donovani: intraspecific polymorphisms of Sudanese isolates revealed by PCR-based analyses and DNA sequencing. Exp Parasitol 97:35\u201344","journal-title":"Exp Parasitol"},{"key":"3222_CR9","doi-asserted-by":"crossref","first-page":"31010","DOI":"10.1074\/jbc.M403959200","volume":"279","author":"B Gourbal","year":"2004","unstructured":"Gourbal B, Sonuc N, Bhattacharjee H, Legare D, Sundar S, Ouellette M, Rosen BP, Mukhopadhyay R (2004) Drug uptake and modulation of drug resistance in Leishmania by an aquaglyceroporin. J Biol Chem 279:31010\u201331017","journal-title":"J Biol Chem"},{"key":"3222_CR10","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1056\/NEJM199912093412403","volume":"341","author":"TK Jha","year":"1999","unstructured":"Jha TK, Sundar S, Thakur CP, Bachmann P, Karbwang J, Fischer C, Voss A, Berman J (1999) Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. N Engl J Med 341:1795\u20131800","journal-title":"N Engl J Med"},{"key":"3222_CR11","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/AAC.01233-08","volume":"53","author":"D Kumar","year":"2009","unstructured":"Kumar D, Kulshrestha A, Singh R, Salotra P (2009) In vitro susceptibility of field isolates of Leishmania donovani to miltefosine and amphotericin B: correlation with sodium antimony gluconate susceptibility and implications for treatment in areas of endemicity. Antimicrob Agents Chemother 53:835\u2013838","journal-title":"Antimicrob Agents Chemother"},{"key":"3222_CR12","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/jac\/dkp468","volume":"65","author":"S Mandal","year":"2010","unstructured":"Mandal S, Maharjan M, Singh S, Chatterjee M, Madhubala R (2010) Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India. J Antimicrob Chemother 65:496\u2013507","journal-title":"J Antimicrob Chemother"},{"key":"3222_CR13","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/0140-6736(92)92952-C","volume":"340","author":"M Mishra","year":"1992","unstructured":"Mishra M, Biswas UK, Jha DN, Khan AB (1992) Amphotericin versus pentamidine in antimony-unresponsive Kala-Azar. Lancet 340:1256\u20131257","journal-title":"Lancet"},{"key":"3222_CR14","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2174\/092986707780362862","volume":"14","author":"J Mishra","year":"2007","unstructured":"Mishra J, Saxena A, Singh S (2007) Chemotherapy of leishmaniasis: past, present and future. Curr Med Chem 14:1153\u20131169","journal-title":"Curr Med Chem"},{"key":"3222_CR15","doi-asserted-by":"crossref","first-page":"580","DOI":"10.4269\/ajtmh.2009.80.580","volume":"80","author":"BD Pandey","year":"2009","unstructured":"Pandey BD, Pandey K, Kaneko O, Yanagi T, Hirayama K (2009) Relapse of visceral leishmaniasis after miltefosine treatment in a Nepalese patient. Am J Trop Med Hyg 80:580\u2013582","journal-title":"Am J Trop Med Hyg"},{"key":"3222_CR16","doi-asserted-by":"crossref","first-page":"23766","DOI":"10.1074\/jbc.M605214200","volume":"281","author":"FJ Perez-Victoria","year":"2006","unstructured":"Perez-Victoria FJ, Sanchez-Canete MP, Castanys S, Gamarro F (2006) Phospholipid translocation and miltefosine potency require both L. donovani miltefosine transporter and the new protein LdRos3 in Leishmania parasites. J Biol Chem 281:23766\u201323775","journal-title":"J Biol Chem"},{"key":"3222_CR17","first-page":"443","volume-title":"Leishmaniasis","author":"RK Sanyal","year":"1985","unstructured":"Sanyal RK (1985) Leishmaniasis in the Indian subcontinent. In: Chang KP, Bray RS (eds) Leishmaniasis. Elsevier Science, Amsterdam, pp 443\u2013467"},{"key":"3222_CR18","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1074\/jbc.M005423200","volume":"276","author":"P Shaked-Mishan","year":"2001","unstructured":"Shaked-Mishan P, Ulrich N, Ephros M, Zilberstein D (2001) Novel intracellular SbV reducing activity correlates with antimony susceptibility in Leishmania donovani. J Biol Chem 276:3971\u20133976","journal-title":"J Biol Chem"},{"key":"3222_CR19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10156-004-0348-9","volume":"10","author":"S Singh","year":"2004","unstructured":"Singh S, Sivakumar R (2004) Challenges and new discoveries in the treatment of leishmaniasis. J Infect Chemother 10:307\u2013315","journal-title":"J Infect Chemother"},{"key":"3222_CR20","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1046\/j.1537-2995.1996.36996420769.x","volume":"36","author":"S Singh","year":"1996","unstructured":"Singh S, Chaudhry VP, Wali JP (1996) Transfusion-transmitted Kala-Azar in India. Transfusion 36:848\u2013849","journal-title":"Transfusion"},{"key":"3222_CR21","first-page":"73","volume":"31","author":"S Singh","year":"1999","unstructured":"Singh S, Biswas A, Wig N, Aggarwal P, Sood R, Wali JP (1999) A new focus of visceral leishmaniasis in sub-Himalayan (Kumaon) region of northern India. J Commun Dis 31:73\u201377","journal-title":"J Commun Dis"},{"key":"3222_CR22","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1365-4632.2011.04925.x","volume":"50","author":"S Singh","year":"2011","unstructured":"Singh S, Sharma U, Mishra J (2011) Post-Kala-Azar dermal leishmaniasis: recent developments. Int J Dermatol 50:1099\u20131108","journal-title":"Int J Dermatol"},{"key":"3222_CR23","first-page":"733","volume":"3","author":"S Sundar","year":"2007","unstructured":"Sundar S, Olliaro PL (2007) Miltefosine in the treatment of leishmaniasis: clinical evidence for informed clinical risk management. Ther Clin Risk Manag 3:733\u2013740","journal-title":"Ther Clin Risk Manag"},{"key":"3222_CR24","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1086\/318121","volume":"31","author":"S Sundar","year":"2000","unstructured":"Sundar S, More DK, Singh MK, Singh VP, Sharma S, Makharia A, Kumar PC, Murray HW (2000) Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin Infect Dis 31:1104\u20131107","journal-title":"Clin Infect Dis"},{"key":"3222_CR25","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/00034983.1992.11812678","volume":"86","author":"CP Thakur","year":"1992","unstructured":"Thakur CP, Kumar K (1992) Post Kala-Azar dermal leishmaniasis: a neglected aspect of Kala-Azar control programmes. Ann Trop Med Parasitol 86:355\u2013359","journal-title":"Ann Trop Med Parasitol"},{"key":"3222_CR26","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0035-9203(00)90131-7","volume":"94","author":"CP Thakur","year":"2000","unstructured":"Thakur CP, Kanyok TP, Pandey AK, Sinha GP, Messick C, Olliaro P (2000) Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study. Trans R Soc Trop Med Hyg 94:432\u2013433","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"3222_CR27","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/j.1365-2133.2007.07872.x","volume":"156","author":"O Zerpa","year":"2007","unstructured":"Zerpa O, Ulrich M, Blanco B, Polegre M, Avila A, Matos N, Mendoza I, Pratlong F, Ravel C, Convit J (2007) Diffuse cutaneous leishmaniasis responds to miltefosine but then relapses. Br J Dermatol 156:1328\u20131335","journal-title":"Br J Dermatol"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-012-3222-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00436-012-3222-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-012-3222-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T23:40:16Z","timestamp":1562456416000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00436-012-3222-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,18]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["3222"],"URL":"https:\/\/doi.org\/10.1007\/s00436-012-3222-1","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,18]]}}}